SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Senores Pharmaceuticals informs about updates

22 Apr 2025 Evaluate
With reference to the intimations dated March 11, 2025 and March 12, 2025, regarding acquisition of 8454 equity shares from certain shareholders (Public Category) of Havix Group Inc. D/B/A Aavis Pharmaceuticals, Senores Pharmaceuticals has informed that out of the said 8454 equity shares, the acquisition of 7914 equity shares have been completed and acquisition of 540 equity shares is under process due to requirement of certain approvals from Reserve Bank of India (RBI). In view of the above, the time-period for completion of acquisition of the remaining 540 equity shares has been further extended by 60 (sixty) days.

The above information is a part of company’s filings submitted to BSE.

Senores Pharmaceutic Share Price

966.55 34.10 (3.66%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×